CN113812537A - Microecological preparation for promoting gastrointestinal tract health of sows in perinatal period and preparation method thereof - Google Patents
Microecological preparation for promoting gastrointestinal tract health of sows in perinatal period and preparation method thereof Download PDFInfo
- Publication number
- CN113812537A CN113812537A CN202111087970.6A CN202111087970A CN113812537A CN 113812537 A CN113812537 A CN 113812537A CN 202111087970 A CN202111087970 A CN 202111087970A CN 113812537 A CN113812537 A CN 113812537A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- sows
- microecological
- preparation
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 62
- 230000009984 peri-natal effect Effects 0.000 title claims abstract description 49
- 230000036541 health Effects 0.000 title claims abstract description 32
- 230000001737 promoting effect Effects 0.000 title claims abstract description 27
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract description 52
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 56
- 241000193171 Clostridium butyricum Species 0.000 claims abstract description 33
- 229940088594 vitamin Drugs 0.000 claims abstract description 33
- 229930003231 vitamin Natural products 0.000 claims abstract description 33
- 235000013343 vitamin Nutrition 0.000 claims abstract description 33
- 239000011782 vitamin Substances 0.000 claims abstract description 33
- 241000186660 Lactobacillus Species 0.000 claims abstract description 32
- 239000006041 probiotic Substances 0.000 claims abstract description 31
- 235000018291 probiotics Nutrition 0.000 claims abstract description 31
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 30
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 30
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 28
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 28
- 239000011718 vitamin C Substances 0.000 claims abstract description 28
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 28
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 26
- 229960003495 thiamine Drugs 0.000 claims abstract description 26
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 26
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 26
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 26
- 230000000968 intestinal effect Effects 0.000 claims abstract description 24
- 230000002496 gastric effect Effects 0.000 claims abstract description 22
- 239000002068 microbial inoculum Substances 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 206010010774 Constipation Diseases 0.000 claims abstract description 11
- 206010016766 flatulence Diseases 0.000 claims abstract description 9
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 37
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 23
- 241000894006 Bacteria Species 0.000 claims description 19
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 19
- 230000000529 probiotic effect Effects 0.000 claims description 14
- 230000001580 bacterial effect Effects 0.000 claims description 12
- 239000003651 drinking water Substances 0.000 claims description 10
- 235000020188 drinking water Nutrition 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 238000009472 formulation Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 239000004310 lactic acid Substances 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 1
- 239000002054 inoculum Substances 0.000 claims 1
- 244000052616 bacterial pathogen Species 0.000 abstract description 18
- 108091005804 Peptidases Proteins 0.000 abstract description 14
- 239000004365 Protease Substances 0.000 abstract description 9
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 9
- 235000019419 proteases Nutrition 0.000 abstract description 9
- 230000002180 anti-stress Effects 0.000 abstract description 6
- 238000009395 breeding Methods 0.000 abstract description 6
- 230000001488 breeding effect Effects 0.000 abstract description 6
- 230000007661 gastrointestinal function Effects 0.000 abstract description 6
- 231100000699 Bacterial toxin Toxicity 0.000 abstract description 5
- 102000035195 Peptidases Human genes 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 5
- 239000000688 bacterial toxin Substances 0.000 abstract description 5
- 235000019621 digestibility Nutrition 0.000 abstract description 5
- 235000019833 protease Nutrition 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 230000001976 improved effect Effects 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000008946 inflammatory intestinal reaction Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 17
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 14
- 239000002131 composite material Substances 0.000 description 14
- 230000006870 function Effects 0.000 description 11
- 241000186000 Bifidobacterium Species 0.000 description 8
- 230000029087 digestion Effects 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 239000003674 animal food additive Substances 0.000 description 4
- 239000000729 antidote Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 208000028774 intestinal disease Diseases 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 235000021053 average weight gain Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241001112696 Clostridia Species 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000021052 average daily weight gain Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000013101 initial test Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940118696 vibrio cholerae Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a microecological preparation for promoting gastrointestinal health of sows in perinatal period and a preparation method thereof, belongs to the technical field of live pig breeding, and comprises a compound microbial inoculum and compound vitamins, wherein the compound microbial inoculum comprises clostridium butyricum, lactobacillus, saccharomycetes and bacillus subtilis, and the compound vitamins comprise vitamin C and vitamin B1. According to the microecological preparation for promoting the gastrointestinal tract health of the sows in the perinatal period and the preparation method thereof, the intestinal tracts of the sows are protected and the gastrointestinal movement of the sows is enhanced under the action of probiotics, the intestinal delay and the toxic action of pathogenic bacteria are relieved through multivitamins, the gastrointestinal functions are enhanced under the synergistic action of all strains, the intestinal pathogenic bacteria are inhibited, the anti-stress capability is improved, the intestinal stability is maintained, the gastrointestinal health of the sows is promoted, the bacterial toxin is degraded through protease and peptidase besides the inhibition effect on the intestinal pathogenic bacteria, the intestinal inflammatory reaction of the sows is reduced, the feed digestibility is improved, and the microecological preparation can be applied to preventing and treating intestinal flatulence of the sows and improving constipation of the sows.
Description
Technical Field
The invention relates to the technical field of live pig breeding, in particular to a microecological preparation for promoting gastrointestinal tract health of sows in a perinatal period and a preparation method thereof.
Background
The perinatal period is an important time period in the breeding industry, the fetus of the sows in the perinatal period, especially in the late gestation period, is rapidly developed, the energy consumption is improved, the food intake is rapidly increased, and the improvement of the health condition of the sows in the perinatal period has important significance for improving the immunity of piglets and reducing the occurrence of infectious diseases.
During the perinatal period, the uterus of the sow expands and compresses the intestinal tract to cause the digestive ability of the sow to be reduced, the sow is in a high-incidence stage of digestive tract diseases such as flatulence, constipation and the like, the reproductive performance of the sow is influenced, the life of the sow is seriously threatened, and the serious loss is brought to the breeding industry, so that the intestinal tract health of the sow is promoted, the incidence of the digestive tract diseases of the sow during the perinatal period is reduced, and the sow is an urgent need in the field of live pig breeding at present.
Disclosure of Invention
The invention aims to provide a microecological preparation for promoting the gastrointestinal tract health of sows in the perinatal period and a preparation method thereof, and the microbial preparation can be widely applied to preventing and treating intestinal flatulence of sows and improving constipation of sows, and can be used for enhancing the gastrointestinal function, inhibiting intestinal pathogenic bacteria, improving the anti-stress capability, maintaining the intestinal stability and promoting the gastrointestinal health of the sows under the synergistic effect of all strains so as to solve the problems in the background art.
In order to achieve the purpose, the invention provides the following technical scheme:
the microecological preparation for promoting the gastrointestinal health of the sows in the perinatal period comprises a compound microbial inoculum and compound vitamins, wherein the compound microbial inoculum comprises clostridium butyricum, lactobacillus, saccharomycetes and bacillus subtilis, and the compound vitamins comprise vitamin C and vitamin B1.
Furthermore, the composite microbial inoculum uses corn dextrin as a carrier, and the composite vitamin is selected from powder.
Further, the proportion of each component in the microecological preparation is clostridium butyricum; a lactic acid bacterium; a yeast; b, bacillus subtilis; vitamin C; vitamin B1 ═ 2: 1: 2: 2: 1: 1.
furthermore, the final system of the microecological preparation has the probiotic viable count of 109CFU/g。
Further, the microecologics and drinking water are mixed according to the ratio of 1: 100, or the microecological preparation and the daily ration are mixed according to the ratio of 1: 100, and the probiotics include but are not limited to drinking water and feed.
Further, the microecological preparation is applied to preventing and treating intestinal flatulence of sows and improving constipation of the sows.
According to another aspect of the present invention, there is provided a method for preparing a microecological formulation for promoting the gastrointestinal health of perinatal sows, comprising the steps of:
s1: according to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, taking the fungus powder and the vitamin powder;
s2: mixing uniformly to obtain microecological preparation, and making the final system probiotic viable count greater than 109CFU/g；
S3: packaging the prepared microecologics, and taking the microecologics according to the ratio of 1: the probiotics are mixed with the adjuvant in a ratio of 100.
Further, according to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, uniformly mixing the bacterial powder and the vitamin powder to prepare a powdery microecological preparation, wherein the ratio of the bacterial powder to the vitamin powder is 1: the powdered probiotic is mixed with drinking water in a ratio of 100.
Further, according to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, uniformly mixing the bacterial powder and the vitamin powder, adding 20-24% of distilled water into the uniformly mixed powder, granulating by adopting a wet method, and drying, wherein the ratio of the bacterial powder to the vitamin powder is 1: the granulated probiotics were mixed with the ration in a ratio of 100.
Compared with the prior art, the invention has the beneficial effects that:
according to the microecological preparation for promoting the gastrointestinal tract health of the sows in the perinatal period and the preparation method thereof, the intestinal tracts of the sows are protected and the gastrointestinal movement of the sows is enhanced under the action of probiotics, wherein the clostridium butyricum can improve the anti-stress capability, the feed conversion rate and the growth performance; metabolites of lactobacillus can inhibit the growth of intestinal pathogenic bacteria and accelerate gastrointestinal emptying; the yeast can regulate intestinal disorder and promote the stability of flora; the bacillus subtilis can generate protease and promote the digestion function of intestinal tracts, the intestinal tract delay and the toxic action of pathogenic bacteria are reduced through the multivitamins, and the vitamin B1 can promote the gastrointestinal functions and increase the energy utilization rate of the gastrointestinal tracts; compared with the existing fermented feed preparation, the vitamin C serving as a wide antidote and antioxidant can not only inhibit pathogenic bacteria in intestinal tracts, but also degrade bacterial toxins by protease and peptidase, reduce inflammatory reaction in the intestinal tracts of sows, improve the digestibility of feed, and can be widely applied to preventing and treating intestinal flatulence of sows and improving constipation of sows.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example one
The microecological preparation for promoting the gastrointestinal tract health of the sows in the perinatal period comprises a composite microbial inoculum and composite vitamins, wherein the composite microbial inoculum uses corn dextrin as a carrier, the composite vitamins are selected from powder, the composite microbial inoculum comprises clostridium butyricum, lactobacillus, saccharomycetes and bacillus subtilis, the composite vitamins comprise vitamin C and vitamin B1, and the proportion of each component in the microecological preparation is clostridium butyricum; a lactic acid bacterium; a yeast; b, bacillus subtilis; vitamin C; vitamin preparationB1 ═ 2: 1: 2: 2: 1: 1, the final system probiotic viable count of the microecological preparation is 109CFU/g。
The intestinal tract of the sow is protected and the gastrointestinal movement of the sow is enhanced through the action of probiotics, wherein the clostridium butyricum can improve the anti-stress capability, the feed conversion rate and the growth performance; metabolites of lactobacillus can inhibit the growth of intestinal pathogenic bacteria and accelerate gastrointestinal emptying; the yeast can regulate intestinal disorder and promote the stability of flora; the bacillus subtilis can generate protease and promote the digestion function of intestinal tracts, the intestinal tract delay and the toxic action of pathogenic bacteria are reduced through the multivitamins, and the vitamin B1 can promote the gastrointestinal functions and increase the energy utilization rate of the gastrointestinal tracts; compared with the existing fermented feed preparation, the vitamin C serving as a wide antidote and antioxidant can not only inhibit pathogenic bacteria in intestinal tracts, but also degrade bacterial toxins by producing protease and peptidase, reduce inflammatory reaction in the intestinal tracts of sows and improve the digestibility of feed.
The microecological preparation is applied to preventing and treating intestinal flatulence of sows and improving constipation of sows.
In order to better show the preparation process of the microecological preparation for promoting the gastrointestinal tract health of the perinatal sows, the embodiment now provides a preparation method of the microecological preparation for promoting the gastrointestinal tract health of the perinatal sows, which comprises the following steps:
s1: according to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, taking the fungus powder and the vitamin powder;
s2: mixing uniformly to obtain microecological preparation, and making the final system probiotic viable count greater than 109CFU/g；
S3: packaging the prepared microecologics, and taking the microecologics according to the ratio of 1: the probiotics are mixed with the adjuvant in a ratio of 100.
According to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, uniformly mixing the bacterial powder and the vitamin powder to prepare a powdery microecological preparation, wherein the ratio of the bacterial powder to the vitamin powder is 1: the powdered probiotic is mixed with drinking water in a ratio of 100.
The clostridium butyricum is applied to feed as a feed additive, and can embody five biological characteristics in animal intestinal tracts: the feed additive can promote the proliferation and development of beneficial flora (bifidobacteria and lactobacilli) in the intestinal tract of animals, inhibit the growth and reproduction of harmful bacteria and putrefying bacteria in the intestinal tract, correct the disturbance of the flora in the intestinal tract and reduce the occurrence of enterotoxin; secondly, substances such as B vitamins, vitamin K, amylase and the like can be generated in the intestinal tracts of animals, so that the health-care function is realized; thirdly, the main metabolite of the clostridium butyricum, namely butyric acid, is a main nutrient substance for regeneration and repair of intestinal epithelial tissue cells; fourthly, anaerobic or facultative anaerobic bacillus is not affected by gastric acid, bile acid and the like; fifthly, the feed additive has strong tolerance to various feed antibiotics and can be used in a compatible way, and the clostridium butyricum is used as a new feed additive, and has important significance for reducing abuse of antibiotic products in the current feed, reducing residue of medicines in meat, reducing drug resistance of animal bacteria and guaranteeing animal health.
Experiments show that the fecal flora of healthy people is mainly anaerobic bacteria, and the bifidobacteria is one of the highest and most common normal flora in human and animal bodies, Zhangrong and the like prove that the flora imbalance in irritable bowel syndrome patients is represented as the reduction of the total anaerobic bacteria, bifidobacteria and lactobacilli in the main proportion in the fecal flora, while the number of the potentially pathogenic clostridia which occupy less in the intestinal flora proportion is obviously increased, after the treatment by clostridium butyricum, the bifidobacteria, the spore-free anaerobic bacteria, the coliform bacteria, the enterococcus and the lactic acid bacteria in the fecal flora have no obvious difference with healthy people, the bifidobacteria and the lactobacilli which occupy more in the intestinal proportion are obviously increased, the clostridia with potential pathogenicity are obviously reduced, and clinical symptoms are correspondingly and obviously improved; the research reports of Zhao Xi and the like that the butyric acid bacteria preparation increases the number of bifidobacteria in intestinal tracts, the difference is very obvious (P is less than or equal to 0.01), the number of lactobacillus is increased, and the difference is obvious (P is less than or equal to 0.05); furiwu et al demonstrated that the subjects had no significant change in the amount of Enterobacter, enterococcus, and Bacteroides after taking the butyric acid bacteria preparation. The number of bifidobacteria and lactobacilli is increased, and the difference is very significant (P is less than or equal to 0.01); studies on the in vitro biological antagonism of intestinal pathogenic bacteria by Zhangxuepin and other butyric acid bacteria preparations show that clostridium butyricum and bifidobacterium can obviously inhibit the growth and reproduction of Escherichia coli, typhoid bacillus and dysentery bacillus in vitro; research of Ladrochloa, etc. shows that the butyric acid bacteria has antagonism to vibrio cholerae and has the function of inhibiting vibrio cholerae; experiments of Lvkangsu and the like prove that the butyric acid bacteria and the bifidobacterium infantis can obviously inhibit the growth of clostridium difficile, and the combination of the two bacteria shows stronger biological antagonism than that of the two bacteria when the two bacteria are respectively cultured independently, and a series of experimental researches prove that the butyric acid bacteria preparation has important significance for adjusting the intestinal microecology.
The lactobacillus has important function in maintaining the health of human and higher animals, and can improve the digestion and absorption of protein, lactose, calcium and other nutrients and produce vitamins for the digestion and absorption of the organisms in the aspect of nutrition physiology; can inhibit the reproduction of putrefying bacteria and pathogenic bacteria in intestinal tract, reduce the content of blood ammonia and cholesterol in blood, and has the function of regulating intestine to maintain the balance of flora in intestinal tract; the lactobacillus has the immunoregulation function, such as the obvious functions of promoting cell division, promoting antibody generation, activating macrophage, inducing interferon generation and the like, and improving the disease resistance of organisms; the lactobacillus has activating effect on macrophage, and can enhance cytotoxicity of macrophage.
The yeast is widely used as protein supplement of animal feed, and can promote growth and development of animals, shorten breeding period, increase meat and egg amount, improve meat quality and lean meat percentage, improve coat glossiness, and enhance disease resistance of young livestock.
The bacillus subtilis is a probiotic strain commonly added in animal feed, and is added into the animal feed in a spore form; spores are living cells in a dormant state, can tolerate adverse environments in the feed processing process, are stable and easy to store after being prepared into a microbial inoculum, and can be rapidly recovered and propagated after entering animal intestinal tracts; the bacillus subtilis can exert the probiotic characteristics after being recovered and proliferated in animal intestinal tracts, comprises the functions of improving animal intestinal flora, enhancing the immunity of organisms, providing various enzymes required by animals and the like, can make up the deficiency of endogenous enzymes in the animals, promotes the growth and development of the animals, and has remarkable probiotic effect.
Example two
The microecological preparation for promoting the gastrointestinal tract health of the sows in the perinatal period comprises a composite microbial inoculum and composite vitamins, wherein the composite microbial inoculum uses corn dextrin as a carrier, the composite vitamins are selected from powder, the composite microbial inoculum comprises clostridium butyricum, lactobacillus, saccharomycetes and bacillus subtilis, the composite vitamins comprise vitamin C and vitamin B1, and the proportion of each component in the microecological preparation is clostridium butyricum; a lactic acid bacterium; a yeast; b, bacillus subtilis; vitamin C; vitamin B1 ═ 2: 1: 2: 2: 1: 1, the final system probiotic viable count of the microecological preparation is 109CFU/g。
The intestinal tract of the sow is protected and the gastrointestinal movement of the sow is enhanced through the action of probiotics, wherein the clostridium butyricum can improve the anti-stress capability, the feed conversion rate and the growth performance; metabolites of lactobacillus can inhibit the growth of intestinal pathogenic bacteria and accelerate gastrointestinal emptying; the yeast can regulate intestinal disorder and promote the stability of flora; the bacillus subtilis can generate protease and promote the digestion function of intestinal tracts, the intestinal tract delay and the toxic action of pathogenic bacteria are reduced through the multivitamins, and the vitamin B1 can promote the gastrointestinal functions and increase the energy utilization rate of the gastrointestinal tracts; compared with the existing fermented feed preparation, the vitamin C serving as a wide antidote and antioxidant can not only inhibit pathogenic bacteria in intestinal tracts, but also degrade bacterial toxins by producing protease and peptidase, reduce inflammatory reaction in the intestinal tracts of sows and improve the digestibility of feed.
The microecological preparation is applied to preventing and treating intestinal flatulence of sows and improving constipation of sows.
In order to better show the preparation process of the microecological preparation for promoting the gastrointestinal tract health of the perinatal sows, the embodiment now provides a preparation method of the microecological preparation for promoting the gastrointestinal tract health of the perinatal sows, which comprises the following steps:
s1: according to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, taking the fungus powder and the vitamin powder;
s2: mixing uniformly to obtain microecological preparation, and making the final system probiotic viable count greater than 109CFU/g；
S3: packaging the prepared microecologics, and taking the microecologics according to the ratio of 1: the probiotics are mixed with the adjuvant in a ratio of 100.
According to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, uniformly mixing the bacterial powder and the vitamin powder, adding 20-24% of distilled water into the uniformly mixed powder, granulating by adopting a wet method, and drying, wherein the ratio of the bacterial powder to the vitamin powder is 1: the granulated probiotics were mixed with the ration in a ratio of 100.
Experiment one
The microecologics prepared by the preparation method are taken by perinatal sows to study the influence of the microecologics on the growth performance of the perinatal sows, wherein three groups of perinatal sows are selected, the number of the perinatal sows in each group is five, the initial weights of the perinatal sows have no significant difference (P is more than 0.05), the health condition is good, the control group is directly fed by basic ration, and the first group adopts the basic ration plus 1: feeding the powder microecologics mixed with drinking water in a ratio of 100, wherein the second group adopts basic ration and takes 1: the granular probiotics and the daily ration are mixed for feeding in a proportion of 100.
Under the same feeding management conditions, feeding by the same feeder for 3 times a day, wherein the feeding amount is based on the full and waste, drinking water freely, carrying out conventional immunization and disinfection, weighing individual weight of the pig in 12h on an empty stomach at the end of a pre-test period as the initial test weight, measuring the temperature and the relative humidity of a pigsty at 6:00, 14:00, 18:00 and 22:00 every day, calculating the average weight gain, the average daily weight gain and the total feeding amount, and observing the excrement condition of the sows in the perinatal period, wherein the recording conditions are as follows:
| item | Control group | First group | First group |
| Number/head of experimental sows | 5 | 5 | 5 |
| Average initial weight/kg | 132.45 | 132.74 | 132.68 |
| Average weight gain/kg | 16.34 | 18.52 | 18.48 |
| Average daily gain/kg | 0.42 | 0.65 | 0.63 |
| Total feed amount/kg | 245.37 | 267.49 | 267.38 |
| Condition of stool | The stool is in a shape of a hard bang | The stool is banana-shaped | The stool is banana-shaped |
As can be seen from the table, the initial body weight difference of the perinatal sows of each group of experiments is not obvious, but after the group of perinatal sows are fed for a period of time, the perinatal sows fed with the microecologics have more average daily gain and good stool, and the constipation is relieved, so that the growth condition of the perinatal sows is good.
Experiment two
Clostridium butyricum, lactobacillus, saccharomycetes, bacillus subtilis, vitamin C and vitamins are prepared into microecologics in different proportions, the prepared microecologics are taken by perinatal sows, the influence of the microecologics on the growth performance of the perinatal sows is researched, wherein four groups of perinatal sows are selected, the number of the perinatal sows in each group is five, the initial weight of the perinatal sows in each group has no significant difference (P is more than 0.05), the health condition is good, and the control group is fed by basic ration; the first group was fed with basal diet + probiotics, wherein clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 2: 2: 2: 1: 1; the second group was fed with basal ration + probiotics, wherein clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1; the third group was fed with basal ration + probiotics, wherein clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 2: 2.
under the same feeding management conditions, feeding by the same feeder for 3 times a day, wherein the feeding amount is based on the full and waste, drinking water freely, carrying out conventional immunization and disinfection, weighing individual weight of the pig in 12h on an empty stomach at the end of a pre-test period as the initial test weight, measuring the temperature and the relative humidity of a pigsty at 6:00, 14:00, 18:00 and 22:00 every day, calculating the average weight gain, the average daily weight gain and the total feeding amount, and observing the excrement condition of the sows in the perinatal period, wherein the recording conditions are as follows:
as can be seen from the table, the initial body weight differences among the perinatal sows for the respective groups tested were not significant, but after a period of feeding, it can be seen that the weight differences according to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, when the microecological preparation is taken by the perinatal sows, the average daily gain of the perinatal sows is large, the excrement is good, the constipation is relieved, and the growth condition of the perinatal sows is the best.
In conclusion, the microecological preparation for promoting the gastrointestinal tract health of the sows in the perinatal period and the preparation method thereof protect the intestinal tracts of the sows and strengthen the gastrointestinal movement of the sows under the action of probiotics, wherein the clostridium butyricum can improve the anti-stress capability, the feed conversion rate and the growth performance; metabolites of lactobacillus can inhibit the growth of intestinal pathogenic bacteria and accelerate gastrointestinal emptying; the yeast can regulate intestinal disorder and promote the stability of flora; the bacillus subtilis can generate protease and promote the digestion function of intestinal tracts, the intestinal tract delay and the toxic action of pathogenic bacteria are reduced through the multivitamins, and the vitamin B1 can promote the gastrointestinal functions and increase the energy utilization rate of the gastrointestinal tracts; compared with the existing fermented feed preparation, the vitamin C serving as a wide antidote and antioxidant can not only inhibit pathogenic bacteria in intestinal tracts, but also degrade bacterial toxins by protease and peptidase, reduce inflammatory reaction in the intestinal tracts of sows, improve the digestibility of feed, and can be widely applied to preventing and treating intestinal flatulence of sows and improving constipation of sows.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be able to cover the technical solutions and the inventive concepts of the present invention within the technical scope of the present invention.
Claims (9)
1. The microecological preparation for promoting the gastrointestinal health of the sows in the perinatal period is characterized by comprising a compound microbial inoculum and compound vitamins, wherein the compound microbial inoculum comprises clostridium butyricum, lactobacillus, saccharomycetes and bacillus subtilis, and the compound vitamins comprise vitamin C and vitamin B1.
2. The microecological preparation for promoting gastrointestinal health of perinatal sows as claimed in claim 1, wherein the complex microbial inoculant comprises corn dextrin as a carrier, and the complex vitamin is selected from powder.
3. The microecological formulation according to claim 1, wherein the ratio of ingredients in the microecological formulation is clostridium butyricum; a lactic acid bacterium; a yeast; b, bacillus subtilis; vitamin C; vitamin B1 ═ 2: 1: 2: 2: 1: 1.
4. the microecological formulation according to claim 1, wherein the microecological formulation has a final probiotic viable count of 10, and is effective for promoting gastrointestinal health of a perinatal sow9CFU/g。
5. The microecological formulation for promoting gastrointestinal health in a perinatal sow as claimed in claim 1, wherein the microecological formulation is mixed with drinking water in a ratio of 1: 100, or the microecological preparation and the daily ration are mixed according to the ratio of 1: 100, and the probiotics include but are not limited to drinking water and feed.
6. The microecological preparation for promoting gastrointestinal health of a perinatal sow as claimed in claim 1, wherein the microecological preparation is used for preventing intestinal flatulence and improving constipation of the sow.
7. A method for preparing a microecological preparation for promoting the gastrointestinal health of perinatal sows as claimed in any one of claims 1 to 6, comprising the steps of:
s1: according to clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, taking the fungus powder and the vitamin powder;
s2: mixing uniformly to obtain microecological preparation, and making the final system probiotic viable count greater than 109CFU/g；
S3: packaging the prepared microecologics, and taking the microecologics according to the ratio of 1: the probiotics are mixed with the adjuvant in a ratio of 100.
8. A method of preparing the microecological formulation according to claim 7 for promoting gastrointestinal health in perinatal sows, wherein the ratio of Clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, uniformly mixing the bacterial powder and the vitamin powder to prepare a powdery microecological preparation, wherein the ratio of the bacterial powder to the vitamin powder is 1: the powdered probiotic is mixed with drinking water in a ratio of 100.
9. A method of preparing the microecological formulation according to claim 7 for promoting gastrointestinal health in perinatal sows, wherein the ratio of Clostridium butyricum: and (3) lactobacillus: yeast: b, bacillus subtilis: vitamin C: vitamin B1 ═ 2: 1: 2: 2: 1: 1, uniformly mixing the bacterial powder and the vitamin powder, adding 20-24% of distilled water into the uniformly mixed powder, granulating by adopting a wet method, and drying, wherein the ratio of the bacterial powder to the vitamin powder is 1: the granulated probiotics were mixed with the ration in a ratio of 100.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111087970.6A CN113812537A (en) | 2021-09-16 | 2021-09-16 | Microecological preparation for promoting gastrointestinal tract health of sows in perinatal period and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111087970.6A CN113812537A (en) | 2021-09-16 | 2021-09-16 | Microecological preparation for promoting gastrointestinal tract health of sows in perinatal period and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113812537A true CN113812537A (en) | 2021-12-21 |
Family
ID=78922187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111087970.6A Pending CN113812537A (en) | 2021-09-16 | 2021-09-16 | Microecological preparation for promoting gastrointestinal tract health of sows in perinatal period and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113812537A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114617201A (en) * | 2022-04-01 | 2022-06-14 | 江南大学 | Feed additive for relieving constipation of sows in gestation period and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103445026A (en) * | 2013-09-11 | 2013-12-18 | 湖南浏阳河饲料有限公司 | Feed used for sow at perinatal period and preparation method of feed |
| CN107772109A (en) * | 2016-08-30 | 2018-03-09 | 湖南山河美生物环保科技股份有限公司 | A kind of plus microbe additive the special mixed fodder of sow |
| CN109430553A (en) * | 2018-11-07 | 2019-03-08 | 淮北佳羊生物科技有限公司 | Improve sow breeding sexual dysfunction additive for microbe feedstuff and preparation method thereof |
| CN109601737A (en) * | 2019-01-14 | 2019-04-12 | 福建傲农生物科技集团股份有限公司 | A kind of pig farm scene fermented feed and its preparation method and application |
| CN110150486A (en) * | 2018-04-03 | 2019-08-23 | 湖南景程电子科技有限公司 | A kind of feed addictive for preventing and treating the intestines problems such as milking sow constipation diarrhea |
| CN112715766A (en) * | 2020-12-25 | 2021-04-30 | 河南佑民生物科技股份有限公司 | Sow health feed capable of improving milk quality and relieving constipation and preparation method thereof |
-
2021
- 2021-09-16 CN CN202111087970.6A patent/CN113812537A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103445026A (en) * | 2013-09-11 | 2013-12-18 | 湖南浏阳河饲料有限公司 | Feed used for sow at perinatal period and preparation method of feed |
| CN107772109A (en) * | 2016-08-30 | 2018-03-09 | 湖南山河美生物环保科技股份有限公司 | A kind of plus microbe additive the special mixed fodder of sow |
| CN110150486A (en) * | 2018-04-03 | 2019-08-23 | 湖南景程电子科技有限公司 | A kind of feed addictive for preventing and treating the intestines problems such as milking sow constipation diarrhea |
| CN109430553A (en) * | 2018-11-07 | 2019-03-08 | 淮北佳羊生物科技有限公司 | Improve sow breeding sexual dysfunction additive for microbe feedstuff and preparation method thereof |
| CN109601737A (en) * | 2019-01-14 | 2019-04-12 | 福建傲农生物科技集团股份有限公司 | A kind of pig farm scene fermented feed and its preparation method and application |
| CN112715766A (en) * | 2020-12-25 | 2021-04-30 | 河南佑民生物科技股份有限公司 | Sow health feed capable of improving milk quality and relieving constipation and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114617201A (en) * | 2022-04-01 | 2022-06-14 | 江南大学 | Feed additive for relieving constipation of sows in gestation period and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1867238B1 (en) | Feeding stuff composition comprising proliferation promoting agent for bifidus bacteria and use of the same | |
| CN103893214A (en) | Probiotics viable bacteria powder produced by whole oat solid-state mixed fermentation and preparation method of probiotics viable bacteria powder | |
| CN102373162B (en) | Lactobacillus salivarius M6 and antibacterial composition containing same | |
| US20230248788A1 (en) | Compositions and related methods for supporting companion animals with gastrointestinal disorders | |
| CN103981123A (en) | Probiotic agent containing Lactobacillus plantarum and Bifidobacterium lactis, and its preparing method | |
| WO1993014187A1 (en) | A bacterial strain of the species bacillus coagulans: its use as a probiotic agent | |
| CN103893219A (en) | Probiotics for preventing and treating pet diarrhea | |
| CN115094012B (en) | Preparation method and application of bacillus coagulans BC-HYC strain microbial inoculum | |
| CN108402320A (en) | A kind of composite probiotics preparations and its application in pig starter feed | |
| CN111513204B (en) | Application of feed additive in promoting intestinal development of weaned piglets | |
| CN111254088A (en) | Bacillus coagulans strain and application thereof | |
| CN108967742A (en) | A kind of compound micro-ecological preparation used for aquiculture and feed | |
| Wang et al. | Bacillus strains improve growth performance via enhancing digestive function and anti-disease ability in young and weaning rex rabbits | |
| CN112438402A (en) | Composite probiotics and preparation method thereof | |
| CN110692847A (en) | Antibiotic-free mixed feed additive for rabbits | |
| CN105231020A (en) | Feed additive composition and preparation method thereof | |
| CN101297679A (en) | Feedstuff additive for improving immunity of livestock and poultry and preparation thereof | |
| CN113812537A (en) | Microecological preparation for promoting gastrointestinal tract health of sows in perinatal period and preparation method thereof | |
| Satık | Effects of kefir as a probiotic source on the performance and health of young dairy calves | |
| CN102757929A (en) | Method for promoting multiplication of clostridium butyricum | |
| CN108277188A (en) | A kind of weanling pig compound microbial culture starter and its application | |
| CN106889615B (en) | Microelement selenium dietary supplement with function of regulating intestinal flora and application thereof | |
| CN113186118B (en) | Composite probiotic preparation for improving sow productivity and preparation method thereof | |
| CN108835420A (en) | A kind of dedicated anaerobic type biological fermentation feed of pregnant sow and preparation method | |
| CN110897166B (en) | Edible composition containing probiotics and casein phosphopeptide with digestion promoting effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211221 |
|
| RJ01 | Rejection of invention patent application after publication |